Cyclocommunol is primarily studied for its potential biological activities, particularly in the field of natural product-based drug discovery. It has shown promising antimicrobial properties, making it a candidate for development in treatments against certain bacterial and fungal infections. Research also indicates anti-inflammatory effects, suggesting possible use in managing inflammatory conditions. Additionally, cyclocommunol has been investigated for its cytotoxic activity against specific cancer cell lines, highlighting its potential in oncology research. Due to its natural origin and structural complexity, it serves as a lead compound for synthesizing derivatives with enhanced therapeutic properties. Most applications remain in the preclinical research phase, focusing on pharmacology and bioactivity evaluation.